Centessa Pharmaceuticals PLC ADR (CNTA) — Defensive Interval Ratio
Centessa Pharmaceuticals PLC ADR (CNTA) has a Defensive Interval Ratio of 2761 days as of March 2026. Defensive assets of $276.61 Million (cash $-, short-term investments $214.16 Million, receivables $62.45 Million) cover 2761 days of daily cash needs of $100.20K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Centessa Pharmaceuticals PLC ADR Defensive Interval Ratio (2020–2025)
This chart shows how Centessa Pharmaceuticals PLC ADR's Defensive Interval Ratio has evolved across 6 annual periods from 2020 to 2025. As of March 2026, the ratio stands at 2761 days, meaning defensive assets of $276.61 Million can fund 2761 days of operations without new revenue. For the complete balance sheet picture, see CNTA total assets.
Annual Defensive Interval Ratio for Centessa Pharmaceuticals PLC ADR (2020–2025)
The table below presents the year-by-year Defensive Interval Ratio for Centessa Pharmaceuticals PLC ADR from 2020 to 2025, covering 6 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See CNTA working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 2496 days | $293.62 Million | $117.63K/day | $- | $233.28 Million | ▲ +1588 days |
| 2024 | 908 days | $144.25 Million | $158.90K/day | $- | $98.96 Million | ▼ -646 days |
| 2023 | 1554 days | $167.67 Million | $107.90K/day | $- | $128.52 Million | ▲ +1299 days |
| 2022 | 254 days | $26.72 Million | $105.04K/day | $- | $0.00 | ▲ +5 days |
| 2021 | 249 days | $16.81 Million | $67.50K/day | $- | $- | ▲ +125 days |
| 2020 | 124 days | $2.93 Million | $23.61K/day | $- | $- | — |